Roth Capital Previews Preclinical PRESERVATION-1 Data; Affirms BioLineRx (BLRX) at 'Buy'

Go back to Roth Capital Previews Preclinical PRESERVATION-1 Data; Affirms BioLineRx (BLRX) at 'Buy'
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.09 +0.06 (1.98%)
Previous Close $3.03    52 Week High $1.63 
Open $2.91    52 Week Low $0.71 
Day High $3.09    P/E N/A 
Day Low $2.80    EPS $0.00 
Volume 7,393